Tetiana
Aleksandrova
Founder and CEO at Subsense
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
Wed May 21 - 5:30 PM EDT/New York (See in local time)
Add to Calendar
05/21/2025 5:30 PM
05/21/2025 05:50 PM
America/New_York
#WTGC2025
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
#WTGC2025
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
https://www.womentech.net/ringcentral
https://www.womentech.net/ringcentral
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
"Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement"
Don’t miss out and join visionaries, innovators, and thought leaders from all over the world at the Women in Tech Global Conference.
Vote by Sharing
Unite 100 000 Women in Tech to Drive Change with Purpose and Impact.
Do you want to see this session? Help increase the sharing count and the session visibility. Sessions with +10 votes will be available to career ticket holders.
Please note that it might take some time until your share & vote is reflected.
Session: Merging Mind and Machine: The Future of BCIs and Nanotechnology in Human Enhancement
The Brain-Computer Interface (BCI) revolution has begun. Now more than ever, companies are tapping into this technology to improve treatments for traumatic brain injuries (TBI) and stroke patients who have lost their ability to speak or move. However, with these advancements come challenges with invasive surgery-related complications and poor spatial and temporal resolution. In this talk, learn about companies like Subsense which is challenging the status quo, leveraging the first-ever non-surgical, nanoparticle-based bidirectional BCI for direct communication and control of neural activity, offering a new paradigm shift in restoring motor function or enhancing rehabilitation therapies.Beyond medical use, the potential applications for this technology are profound. Imagine being able to share thoughts and emotions; to seamlessly and easily communicate with others, to build worlds in your mind, to manage mental health and emotion; and finally to merge with the digital world and artificial intelligence. BCI will be the next transformative technology, and with it, we will strive to expand human potential.
Key Takeaways
- Brain-computer interface (BCI) is making waves in the tech industry, with luminaries investing significant funds to create safe and efficient human-machine interactions.
- While BCI has been touted as the next technology to change the world, we are still in the early stages of innovation with many hurdles at the forefront.
- Non-invasive BCI technologies, like nanoparticles, have the potential to transform the industry, making BCI more accessible than ever before.
Bio
Tetiana Aleksandrova is the CEO and Co-Founder of Subsense, a company pioneering the next generation of brain-computer interfaces (BCI). She recently secured a $20M funding round, accelerating Subsense’s mission to bridge the gap between the human brain and technology. With over a decade in neurotechnology, Tetiana has built and scaled companies at the forefront of BCI innovation.Before Subsense, she co-founded Neiry, growing it into a global leader in non-invasive BCIs, securing $8M in funding, and leading a successful M&A process. Her work has been recognized by awards such as Top 100 Women in Tech, Top 100 Women in Venture, Top 100 Startups, and Breakthrough Medical Device.
In 2025, Subsense was honored with the MedTech Visionary Award for its pioneering work in non-surgical, bidirectional BCI systems. A futuristic speaker, she has shared insights on neurotechnology, AI, and the future of human potential at TEDx, GoGlobal, Women in Tech Global, VRDays, and more. Tetiana is passionate about building world-changing technologies, pushing the boundaries of human potential, and shaping the future of brain-computer interfaces. She is open to discussions on innovation, investment, and partnerships in neurotechnology.
